Stryker Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
July 26, 2022 at 04:05 pm EDT
Share
Stryker Corporation reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was USD 4,493 million compared to USD 4,294 million a year ago. Net income was USD 656 million compared to USD 592 million a year ago. Basic earnings per share from continuing operations was USD 1.73 compared to USD 1.57 a year ago. Diluted earnings per share from continuing operations was USD 1.72 compared to USD 1.55 a year ago.
For the six months, sales was USD 8,768 million compared to USD 8,247 million a year ago. Net income was USD 979 million compared to USD 894 million a year ago. Basic earnings per share from continuing operations was USD 2.59 compared to USD 2.37 a year ago. Diluted earnings per share from continuing operations was USD 2.56 compared to USD 2.34 a year ago.
Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows:
- surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment;
- orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants.
At the end of 2022, the group had 48 production sites worldwide.
Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).